$22.03
0.77% today
Nasdaq, Dec 30, 09:51 pm CET
ISIN
IL0011794802
Symbol
CLBT

Cellebrite DI Target price 2024 - Analyst rating & recommendation

Cellebrite DI Classifications & Recommendation:

Buy
100%

Cellebrite DI Price Target

Target Price $23.00
Price $22.20
Potential
Number of Estimates 7
7 Analysts have issued a price target Cellebrite DI 2025 . The average Cellebrite DI target price is $23.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 8 Analysts recommend Cellebrite DI to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cellebrite DI stock has an average upside potential 2025 of . Most analysts recommend the Cellebrite DI stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 325.11 399.39
20.12% 22.85%
EBITDA Margin 13.32% 24.59%
195.40% 84.67%
Net Margin -27.52% -71.37%
160.67% 159.33%

8 Analysts have issued a sales forecast Cellebrite DI 2024 . The average Cellebrite DI sales estimate is

$399m
Unlock
. This is
3.69% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$401m 4.16%
Unlock
, the lowest is
$397m 3.15%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $325m 20.12%
2024
$399m 22.85%
Unlock
2025
$466m 16.57%
Unlock
2026
$549m 17.91%
Unlock
2027
$606m 10.35%
Unlock
2028
$686m 13.16%
Unlock

7 Analysts have issued an Cellebrite DI EBITDA forecast 2024. The average Cellebrite DI EBITDA estimate is

$98.2m
Unlock
. This is
46.70% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$100m 49.82%
Unlock
, the lowest is
$95.6m 42.81%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $43.3m 254.84%
2024
$98.2m 126.85%
Unlock
2025
$115m 17.04%
Unlock
2026
$137m 18.93%
Unlock
2027
$142m 3.51%
Unlock
2028
$165m 16.61%
Unlock

EBITDA Margin

2023 13.32% 195.40%
2024
24.59% 84.67%
Unlock
2025
24.69% 0.41%
Unlock
2026
24.90% 0.85%
Unlock
2027
23.36% 6.18%
Unlock
2028
24.07% 3.04%
Unlock

6 Cellebrite DI Analysts have issued a net profit forecast 2024. The average Cellebrite DI net profit estimate is

$-285m
Unlock
. This is
11.62% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-266m 17.43%
Unlock
, the lowest is
$-300m 7.10%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-89.5m 172.88%
2024
$-285m 218.59%
Unlock
2025
$53.8m 118.87%
Unlock
2026
$42.8m 20.37%
Unlock

Net Margin

2023 -27.52% 160.67%
2024
-71.37% 159.33%
Unlock
2025
11.56% 116.20%
Unlock
2026
7.80% 32.53%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.43 -1.37
172.88% 218.60%
P/E negative
EV/Sales 10.67

6 Analysts have issued a Cellebrite DI forecast for earnings per share. The average Cellebrite DI <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.37
Unlock
. This is
11.61% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.28 17.42%
Unlock
, the lowest is
$-1.44 7.10%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.43 172.88%
2024
$-1.37 218.60%
Unlock
2025
$0.26 118.98%
Unlock
2026
$0.21 19.23%
Unlock

P/E ratio

Current -14.32 47.47%
2024
-16.20 13.13%
Unlock
2025
85.86 630.00%
Unlock
2026
107.82 25.58%
Unlock

Based on analysts' sales estimates for 2024, the Cellebrite DI stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

10.67
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
11.57
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.06 128.99%
2024
10.67 3.54%
Unlock
2025
9.15 14.22%
Unlock
2026
7.76 15.19%
Unlock
2027
7.03 9.38%
Unlock
2028
6.22 11.63%
Unlock

P/S ratio

Current 11.99 112.35%
2024
11.57 3.56%
Unlock
2025
9.92 14.22%
Unlock
2026
8.41 15.19%
Unlock
2027
7.63 9.38%
Unlock
2028
6.74 11.63%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today